Varenka Rodriguez DiBlasi, Senior Scientist, Boehringer Ingelheim
Varenka Rodriguez DiBlasi, Ph.D. is a Data Scientist focused on Computational Biology. She heads the Exploratory Bioinformatics Group within the Cancer Immunology & Immune Modulation Department at Boehringer Ingelheim in Ridgefield, CT. Her group aims to identify novel target leads with first in class therapeutic potential by utilizing computational biology methods. She also collaborates with biologists to enable multi-omics study design and analysis to validate these targets.
Prior to working at Boehringer Ingelheim she worked in the pharmaceutical industry setting ( Pfizer in Cambridge, MA and at Infinity Pharmaceuticals) and academic settings (Northeastern University, Harvard Medical School, and Johns Hopkins Medical School). Varenka obtained a B.S in Biochemistry from Northeastern University, a Ph.D. in Cellular and Molecular Medicine- Epigenetics & Computational Biology (Andrew Feinberg Lab) from Johns Hopkins Medical School, and is enrolled in various Machine Learning/AI certificate programs via MIT. She is passionate about advancing drug discovery through application of computational methods to challenging problems in collaboration with project teams.